IL31 and Alzheimer disease: Collectively, these findings suggest that OSM contributes to AD pathogenesis and symptom expression by modulating the expression of IL-31, IL-4, and IL-13 receptor subunits on DRG neurons, thereby altering intracellular signaling pathways responsible for regulating the transmission of itch signals to the central nervous system.